Bovie Medical Corporation Stock Nyse
Equities
US10211F1003
Medical Equipment, Supplies & Distribution
Sales 2024 * | 50.01M 68.19M | Sales 2025 * | 54.67M 74.55M | Capitalization | 48.85M 66.61M |
---|---|---|---|---|---|
Net income 2024 * | -26M -35.45M | Net income 2025 * | -24M -32.73M | EV / Sales 2024 * | 0.98 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.89 x |
P/E ratio 2024 * |
-1.88
x | P/E ratio 2025 * |
-2.08
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 82.08% |
Latest transcript on Bovie Medical Corporation
Managers | Title | Age | Since |
---|---|---|---|
Charles Goodwin
CEO | Chief Executive Officer | 58 | 17-12-14 |
Matthew Hill
DFI | Director of Finance/CFO | 56 | 12-03 |
Kari Larson
CTO | Chief Tech/Sci/R&D Officer | - | 19-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lawrence Waldman
BRD | Director/Board Member | 77 | 11-03-14 |
Craig Swandal
BRD | Director/Board Member | 63 | 18-03-08 |
John Andres
BRD | Director/Board Member | 66 | 14-07-16 |
1st Jan change | Capi. | |
---|---|---|
-5.51% | 181B | |
+2.33% | 112B | |
-3.62% | 67.92B | |
+1.52% | 50.1B | |
+8.06% | 44.27B | |
+9.39% | 40.41B | |
+23.35% | 31.95B | |
+0.67% | 25.82B | |
+17.27% | 25.29B |